Correlation between Thromboplastin Sensitivity and In Vitro F1 + 2 Generation Rate

Please copy the URL and add it into your RSS Feed Reader.

Thromb Haemost 1995; 73(03): 547
DOI: 10.1055/s-0038-1653812

Letters to the Editor

Schattauer GmbH Stuttgart

Authors

Guglielmo Mariani

¹Center for Thrombosis, Hematology, Department of Human Biopathology, University of Rome “La Sapienza”, Italy
Gualtiero Palareti

²Department of Angiology and Coagulation Diseases, Policlinic S. Orsola, University of Bologna, Italy
Giuliana Guazzaloca

²Department of Angiology and Coagulation Diseases, Policlinic S. Orsola, University of Bologna, Italy
Alberto Abate

²Department of Angiology and Coagulation Diseases, Policlinic S. Orsola, University of Bologna, Italy
Gian Domenico Di Nucci

¹Center for Thrombosis, Hematology, Department of Human Biopathology, University of Rome “La Sapienza”, Italy
Giovanna Iacopino

¹Center for Thrombosis, Hematology, Department of Human Biopathology, University of Rome “La Sapienza”, Italy

Received 14 July 1994

Accepted 28 November 1994

Publication Date:
09 July 2018 (online)

References
1 WHO Expert Committee on Biological Standardization. 33rd Report. Tech Rep Ser 1983; 687: 61-105

Reference Link Ris
PubMed Search in Google Scholar
2 Aronson DL, Stevan L, Ball AP. Generation of the combined prothrombin activation peptide (FI+2) during the clotting of blood and plasma. J Clin Invest 1977; 60: 1410

Reference Link Ris
Crossref PubMed Search in Google Scholar
3 Rosing J, Tans G. Meizothrombin, a major product of factor Xa-catalized prothrombin activation. Thromb Haemost 1991; 60: 153

Reference Link Ris
Thieme Connect PubMed Search in Google Scholar